Patents by Inventor George B. Benedek
George B. Benedek has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 5540226Abstract: An apparatus is disclosed for using quasielastic light scattering to determine the degree of cataractogenesis of a lens in vivo. By collecting and analyzing light scattered from the lens, it is possible, using the temporal autocorrelation function, to produce a signature of cataractogenesis, accounting for scattering due to immobile scatterers. The components of the cataractogenesis can also be detected by comparing the values of the components of the signature of cataractogenesis to frequency distribution of the components taken from populations or by detecting changes in the values of the components of the signature of cataractogenesis as a function of time.Type: GrantFiled: January 7, 1994Date of Patent: July 30, 1996Assignee: Massachusetts Institute of Technology & Oculon Corp.Inventors: George M. Thurston, George B. Benedek, Douglas L. Hayden, Joyce A. Peetermans, Victor G. Taratuta
-
Patent number: 5427095Abstract: A method and an apparatus are disclosed for using quasielastic light scattering to determine the degree of cataractogenesis of a lens in vivo. By collecting and analyzing light scattered from the lens, it is possible, using the temporal autocorrelation function, to produce a signature of cataractogenesis, accounting for scattering due to substantially immobile scatterers. The component of the temporal autocorrelation function representing the effect of the substantially immobile scatterers is expressed as a function of the measurement delay time. The components of the cataractogenesis can also be detected by comparing the values of the components of the signature of cataractogenesis to frequency distribution of the components taken from populations or by detecting changes in the values of the components of the signature of cataractogenesis as a function of time.Type: GrantFiled: November 9, 1993Date of Patent: June 27, 1995Assignee: Massachusetts Institute of Technology Oculon CorporationInventors: George M. Thurston, Douglas L. Hayden, George B. Benedek
-
Patent number: 5427094Abstract: A method and apparatus for detecting cataractogenesis is disclosed. Quasielastic light scattering data are collected from the lens of an individual to be tested for cataractogenesis. The data are collected from the lens and are processed by an autocorrelator. The data from the autocorrelator are then fit to an autocorrelation function having a component which has a second derivative less than or equal to zero. This autocorrelation function has been found to change predictably with the individual's age and, accordingly, is useful in detecting and determining the degree of cataractogenesis in the individual.Type: GrantFiled: November 8, 1993Date of Patent: June 27, 1995Assignees: Oculon Corporation, Massachusetts Institute of TechnologyInventors: George M. Thurston, Douglas L. Hayden, Mark S. Bowen, George B. Benedek
-
Patent number: 5392776Abstract: A method and apparatus for detecting cataractogenesis is disclosed. Quasielastic light scattering data are collected from the lens of an individual to be tested for cataractogenesis. The data are collected from specific and reproducible sites within the lens by means of measurements made using a reticle in the apparatus and processed by an autocorrelator. The data from the autocorrelator are then fit to a double exponential form of autocorrelation function and the resulting functional form is transformed to produce at least one dimensionless parameter F.sub.mos. This parameter has been found to change predictably with the individual's age and, accordingly, is useful in detecting and determining the degree of cataractogenesis in the individual.Type: GrantFiled: September 21, 1992Date of Patent: February 28, 1995Assignee: Oculon CorporationInventors: George M. Thurston, Douglas L. Hayden, Victor G. Taratuta, Joyce A. Peetermans, George B. Benedek
-
Patent number: 5284874Abstract: The present invention relates to methods and pharmaceutical reagents for decreasing the phase separation temperature and inhibiting the formation of high molecular weight aggregates in eye lenses, thereby inhibiting or reversing cataract formation.Type: GrantFiled: September 9, 1992Date of Patent: February 8, 1994Assignee: Massachusetts Institute of TechnologyInventors: John I. Clark, George B. Benedek
-
Patent number: 5279296Abstract: A method and an apparatus are disclosed for using quasielastic light scattering to determine the degree of cataractogenesis of a lens in vivo. By collecting and analyzing light scattered from the lens, it is possible, using the temporal autocorrelation function, to produce a signature of cataractogenesis, accounting for scattering due to immobile scatterers. The components of the cataractogenesis can also be detected by comparing the values of the components of the signature of cataractogenesis to frequency distribution of the components taken from populations or by detecting changes in the values of the components of the signature of cataractogenesis as a function of time.Type: GrantFiled: January 4, 1991Date of Patent: January 18, 1994Assignee: Oculon CorporationInventors: George M. Thurston, George B. Benedek, Douglas L. Hayden, Joyce A. Peetermans, Victor G. Taratuta
-
Patent number: 5091421Abstract: The present invention relates to methods and pharmaceutical reagents for decreasing the phase separation temperature and inhibiting the formation of high molecular weight aggregates in eye lenses, thereby inhibiting or reversing cataract formation.Type: GrantFiled: December 15, 1989Date of Patent: February 25, 1992Assignee: Massachusetts Institute of TechnologyInventors: John I. Clark, George B. Benedek, Roelant J. Siezen, John A. Thomson, Simon H. Friedman
-
Patent number: 5072731Abstract: An apparatus is disclosed for using quasielastic light scattering to determine the degree of cataractogenesis of a lens in vivo. By collecting and analyzing light scattered from the lens, it is possible, using the autocorrelation function or the power spectrum, to separate the fluctuations into two components: one caused by fast diffusing proteins and one caused by slow diffusing protein aggregates. This data may be applied to an experimentally determined and theoretically deduced universal curve in order to determine quantitatively the degree of cataractogenesis at that particular location in the lens.Type: GrantFiled: September 17, 1990Date of Patent: December 17, 1991Assignee: Massachusetts Institute of TechnologyInventors: Victor G. Taratuta, George M. Thurston, George B. Benedek
-
Patent number: 4993827Abstract: A method is disclosed to determine the degree of cataractogenesis of a lens in vivo. By collecting and determining the intensity of light scattered from a measurement location in the lens and comparing this value to the intensity of light scattered by a normal, clear lens region or a calibrating element, it is possible to determine the degree of cataractogenesis at the specific measurement location. This data may be applied to an experimentally determined and theoretically deduced universal curve in order to determine quantitatively the degree of cataractogenesis at that particular location in the lens.Type: GrantFiled: January 13, 1989Date of Patent: February 19, 1991Assignee: Massachusetts Institute of TechnologyInventors: George B. Benedek, Peter C. Magnante
-
Patent number: 4957113Abstract: A method is disclosed for using quasielastic light scattering to determine the degree of cataractogenesis of a lens in vivo. By collecting and analyzing light scattered from the lens, it is possible, using the autocorrelation function or the power spectrum, to separate the fluctuations into two components: one caused by fast diffusing proteins and one caused by slow diffusing protein aggregates. This data may be applied to an experimentally determined and theoretically deduced universal curve in order to determine quantitatively the degree of cataractogenesis at that particular location in the lens.Type: GrantFiled: January 8, 1990Date of Patent: September 18, 1990Assignee: Massachusetts Institute of TechnologyInventor: George B. Benedek
-
Patent number: 4665089Abstract: Cataract in mammalian lenses can be prevented or reversed by applying a solution of an imidoester, a N-hydroxysuccinimide-ester or hydrogen peroxide to the lens under conditions that permit the solution to interact with the lens constituents.Type: GrantFiled: March 21, 1985Date of Patent: May 12, 1987Assignee: Massachusetts Institute of TechnologyInventors: Roelant J. Siezen, Christophe M. Coppin, George B. Benedek
-
Patent number: 4526789Abstract: Cataract formation in mammalian lenses can be prevented or reversed by applying a solution of an aldehyde, an acrylamide or a glycol to the lens under conditions that permit the solution to interact with the lens constituents.Type: GrantFiled: September 19, 1983Date of Patent: July 2, 1985Assignee: Massachusetts Institute of TechnologyInventors: John I. Clark, Loretta S. Mengel, George B. Benedek
-
Patent number: 4474817Abstract: Cataract formation in mammalian lenses can be prevented or reversed by applying a solution of an aldehyde, an acrylamide or a glycol to the lens under conditions that permit the solution to interact with the lens constituents.Type: GrantFiled: June 9, 1982Date of Patent: October 2, 1984Assignee: Massachusetts Institute of TechnologyInventors: John I. Clark, Loretta S. Mengel, George B. Benedek
-
Patent number: 4351826Abstract: Cataract formation in mammalian lenses can be prevented or reversed by applying a solution of an aldehyde, an acrylamide or a glycol to the lens under conditions that permit the solution to interact with the lens constituents.Type: GrantFiled: February 29, 1980Date of Patent: September 28, 1982Assignee: Massachusetts Institute of TechnologyInventors: John I. Clark, Loretta S. Mengel, George B. Benedek
-
Patent number: 4350677Abstract: A method and compositions are provided to effect optimization of methods for determining concentrations of antibodies or antigens. Particles coated with an antigen or an antibody are suspended in an aqueous medium where pH and ionic strength are controlled so that the coulomb effect and the van der Waals forces on and exerted by the particles are balanced.Type: GrantFiled: February 12, 1979Date of Patent: September 21, 1982Assignee: Massachusetts Institute of TechnologyInventors: Gustav K. von Schulthess, Richard J. Cohen, George B. Benedek
-
Patent number: 4174952Abstract: Method and apparatus for determining the concentration of any of a wide range of antigen or antibody molecules with a high degree of specificity, accuracy and sensitivity. Antigen or antibody concentration is determined by effecting an agglutination reaction between carrier particles in a liquid medium, exposing the liquid medium to a beam of light, and measuring the ratio of the intensities of light scattered at two different angles as a function of antigen or antibody concentration. The unknown concentration of antibody or antigen is determined by comparison with similar measurements of the anisotropy ratio using known concentrations of the molecule being tested for. The agglutination reaction is performed using carrier particles coated with an agglutinant. The carrier particles should be fairly uniform in size and their diameter can be less than or comparable to the wavelength of light.Type: GrantFiled: January 23, 1978Date of Patent: November 20, 1979Assignee: Massachusetts Institute of TechnologyInventors: David S. Cannell, Marzio Giglio, George B. Benedek, Gustav K. von Schulthess, Richard J. Cohen
-
Patent number: 4164558Abstract: A method and compositions are provided to effect optimization of methods for determining concentrations of antibodies or antigens. Particles coated with an antigen or an antibody are suspended in an aqueous medium where pH and ionic strength are controlled so that the coulomb effect and the van der Waals forces on and exerted by the particles are balanced.Type: GrantFiled: November 22, 1976Date of Patent: August 14, 1979Assignee: Massachusetts Institute of TechnologyInventors: Gustav K. von Schulthess, Richard J. Cohen, George B. Benedek
-
Patent number: 4080264Abstract: This inventin provides a means for determining the concentration of any of a wide range of antibody or antigen molecules with a high degree of specificity, accuracy and sensitivity. Antigen or antibody concentration is determined by effecting an agglutination reaction in a liquid medium and determining the mean diffusion constant of the agglutinated reaction product by quasi-elastic light scattering spectroscopy. The measured mean diffusion constant then is compared with a standard quantitative relationship between mean diffusion constant and concentration of the antigen or antibody being tested. By this means one may specifically ascertain the absolute concentration of the antigen or antibody in question in the sample being analyzed. In addition to detecting antigen or antibody molecules, the process of this invention can be used to determine the concentration of any substance capable of specifically promoting or inhibiting an agglutination reaction such as viruses, white blood cells or the like.Type: GrantFiled: March 1, 1976Date of Patent: March 21, 1978Assignee: Massachusetts Institute of TechnologyInventors: Richard J. Cohen, George B. Benedek